SCHEMBL4281352

SCHEMBL4281352

Cc1ccc(S(=O)(=O)N2Cc3[nH]nc(NC(=O)c4ccc(N5CCN(C)CC5)cc4)c3C2)cc1

nearest known ligand 0.69

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
IGF1R P08069 2/20 0.69
AURKA O14965 13/20 0.58
AURKB Q96GD4 8/20 0.58
ALK Q9UM73 2/20 0.57
LIMK1 P53667 3/20 0.56
FLT3 P36888 3/20 0.56
LIMK2 P53671 2/20 0.56
AURKC Q9UQB9 2/20 0.56
ABL1 P00519 4/20 0.55
BCR P11274 3/20 0.55
PLK1 P53350 2/20 0.55
NTRK1 P04629 5/20 0.55
RET P07949 3/20 0.55
FGFR1 P11362 3/20 0.55
CDK2 P24941 3/20 0.55
NTRK3 Q16288 3/20 0.55
NTRK2 Q16620 3/20 0.55
PLK4 O00444 2/20 0.55
JAK2 O60674 2/20 0.55
MAP4K4 O95819 2/20 0.55

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4282755 0.93 IGF1R (0.69) IGF1RAURKAAURKBALKLIMK1
SCHEMBL4281984 0.92 IGF1R (0.76) IGF1RAURKAAURKBALKLIMK1
SCHEMBL4282057 0.92 IGF1R (0.68) IGF1RAURKAAURKBALKLIMK1
SCHEMBL2915850 0.92 IGF1R (0.70) IGF1RAURKAAURKBALKLIMK1
SCHEMBL4279609 0.91 IGF1R (0.66) IGF1RAURKAAURKBALKLIMK1
SCHEMBL4285181 0.91 IGF1R (0.69) IGF1RAURKAAURKBALKLIMK1
SCHEMBL4278099 0.90 IGF1R (0.68) IGF1RAURKAAURKBALKLIMK1
SCHEMBL4285399 0.90 IGF1R (0.65) IGF1RAURKAAURKBALKLIMK1
SCHEMBL4280719 0.88 IGF1R (0.72) IGF1RAURKAAURKBALKLIMK1
SCHEMBL15327647 0.88 IGF1R (0.89) IGF1RAURKAAURKBALKLIMK1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20090136513-A1 BICYCLO-PYRAZOLES ACTIVE AS KINASE INHIBITORS NERVIANO MEDICAL SCIENCES S.R.L (IT) 2009-05-28 US claimed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090136513-A1 BICYCLO-PYRAZOLES ACTIVE AS KINASE INHIBITORS MAP3K19, CDK2, MAP3K1 IGF1R 530/4885AURKA 42/4885AURKB 68/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.